Abstract.
In IT IS NOW established that the major effect of opiate or opioid peptide on gonadotropin secretion which is mediated by mu receptors is an inhibition of luteinizing hormone (LH) and a facilitation of prolactin (PRL), although there an opposite effect occurs occasionally due to the dosage administered. Morphine, a preferential mu agonist, although interacting with the delta site too in rats, either male or female and either intact or gonadectomized.
Other specific mu receptor agonists, morphiceptin [12] and DAGO [13] , inhibited LH secretion and facilitated PRL secretion. In contrast to this, the effect on gonadotropin which is mediated by delta receptors has been inconsistent. Delta agonists, DRP [ 12] , and DPDPE [ 14] . inhibited LH secretion, but DTE12 had no effect affinity with delta receptors did produce an increase in LH secretion [12, 15] . Further, it has been reported that DRP [12] and DPDPE [14, 16] , had no effect on PRL secretion, and Leuenkephalin had a stimulatory [17] , inhibitory [12] or no [18] effect on PRL secretion. Therefore, the purpose of the present investigation was to study the effect of a preferential delta receptor antagonist ICI 154,129 on LH and PRL secretion in rats in proestrus.
Materials and Methods

Animals
Adult female rats of Wistar strain were maintained under controlled lighting conditions (lights on 0500-1900 h), with food and water available ad libitum. Cyclicity was monitored daily by taking vaginal smears either before or after the implantation of guide cannulae into the brain. were collected for a 9-h period (1100-2000h) at 1-h intervals except for the period 1300-1500h in which sampling was done at 20-min intervals in order to assess the acute effects of drugs injected at 1300h. Samples at 1300h were taken just prior to the injection.
Hormone assay
Serum concentrations of LH and PRL were measured by the double-antibody radioimmunoassay with materials supplied by NIDDK and are expressed in terms of rat N I H-LH-Sl and NIH-PRL-RP1, respectively. Two assays were run for each of LH and PRL, and the intra-and interassay coefficient of variation (CV) estimated in 5 replicates of stock serum at the mean LH and PRL concentration of 5.5 and 36.3 ng/ml, respectively, were 5.5 and 10.7% for LH, and 7.9 and 15.2% for PRL. 2. Afternoon experiment LH: Animals injected with saline into the third ventricle at 1300 h showed an afternoon increase in serum LH (Fig.2) . Mean LH concentrations at 1440-1700h were significantly greater (p<0.05 or 0.01) than at 1100-1300h, peaking at 1600h. In ICI 154,129-injected animals, an afternoon increase in LH occurred in advance and was of greater magnitude. The LH concentration at 1400-1700h was significantly greater than at 1100-1300h, with the peak occurring at 1440h, more than 1h earlier than in saline-injected animals. Compared to saline-injected control animals at corresponding times, values at 1400-1500h were significantly greater (p<0.05 or 0.01). Further the peak LH concentration at 1440 showed about a twofold increase over the peak LH at 1600 h in the control animals. PRL: In all the animals, the mean serum PRL concentration was considerably greater at 1300 h than before, although not significantly different (Fig. 3) . The injection of saline into the third ventricle at 1300h caused the PRL concentration at 1320h to be lower, but an afternoon increase occurred thereafter, peaking at 1400-1800h with a significant change compared to the concentration at 1100 and 1200h (p<0.05). ICI 154,129 injected at 1300 h did not produce a decrease in PRL at 1320 h. The afternoon rise, in which PRL concentrations at 1400-1500h were significantly greater than at 1100 and 1200h, peaked at 1500h. It was noticeable that this increase in PRL secretion ceased thereafter and the PRL level promptly decreased, showing significantly smaller values at 1700 and 1800h than in the saline-injected control animals at corresponding times.
Statistical analysis
For the morning experiment, the mean hormone concentration for each sampling time after drug injection was compared to the mean preinjection concentration by two-way analysis of variance and Duncan's multiple range test. For the afternoon experiment, two-way analysis of variance and Duncan's multiple range test were used to test the statistical significance over time in the mean hormone concentration for each sampling time, and Student's t-test was used to test the significance of difference between the saline-and drug
Discussion
These studies showed that ICI 154,129 produced an advance in and augmentation of the surge of LH secretion when administered intraventricularly just before the critical period for the surge of LH secretion. This finding supports the thesis that there exists in the brain an inhibitory opioid mechanism for the LH surge whose actions are mediated by delta receptors. The inhibitory influence of opioid on the LH surge has been proven in a number of studies examining the effect of naloxone [9, [21] [22] [23] . Naloxone is reported to bind with a higher affinity to mu receptors than to other binding sites [1, 24] , and it has been agreed that the mu subtype is the major receptor mediating the inhibitory influence of opioids on the LH surge. The present results advance the possibility that endogenous opioids that bind with delta receptors also contribute to regulation of the surge of LH secretion.
The effects of ICI 154,129 on the LH secretion in proestrus seemed somewhat different from those of naloxone. Naloxone was effective in eliciting LH release even in the morning of proestrus, as if it had advanced the surge of the LH secretion [9, 21, 22, 25] . However, ICI 154,129 was not; there was not even a sign of LH release after the intraventricular injection in the morning in the present study. It has been suggested that the sensitivity to naloxone of the neural mechanism controlling the LH surge becomes greater just before the critical period than in the morning, followed by a marked decrease thereafter, during the period of LH surge, based on the timedependent changes in naloxone binding to the hypothalamic area [26] and LH secretory response to naloxone [9] . It is then probable that the sensitivity to ICI 154,129 changes more dramatically than that to naloxone, i.e., in the morning almost absent and just before the critical period extremely great. This may mean that during a limited period of proestrus, i.e., before the critical period, there exists a strong inhibitory influence mediated by delta receptors.
In the present study, the surge of PRL secretion was inhibited during the plateau phase, but not during the ascending one, by the intraventricular injection of ICI 154,129, although in the morning it again did not have a significant effect on PRL secretion. This finding is interesting in view of the recent indication that the PRL surge during the ascending phase is elicited by the PRL-releasing factor, but the plateau one probably results from an absence of dopamine input to the pituitary gland [27] . Since opioids have been shown to decrease the release and synthesis of dopamine in the tuberoinfundibular dopamine neurons evoke the inhibition of the PRL surge during the plateau phase. The peak surge will not be ininput to the pituitary gland [27] . In addition, the present results suggest that one of the opioids involved in the inhibition of dopamine release during the surge is that with an affinity with delta receptors. The effect of naloxone on the surge of PRL secretion has been inconsistent [4. 9] . The lack of effectiveness of ICI 154,129 in the morning of proestrus in inhibiting PRL secretion once more suggests that the activity of the delta receptor agonist is greatly increased only during the limited period of proestrus.
